K. Rabe
LungenClinic Grosshansdorf GmbHPoster Author Of 6 e-Posters
A1313 - The Fevipiprant Phase IIIb Systemic Corticosteroid Avoidance Study: SHIELD
Presenter:
Date
05/19/2019
Room
Area E (Hall F, Level 2), KBHCCD
Session Name
A32 - ASTHMA: CLINICAL STUDIES II
A4542 - Seasonal Pattern of COPD Exacerbations in the DYNAGITO Trial
Presenter:
Date
05/21/2019
Room
Area F (Hall F, Level 2), KBHCCD
Session Name
C32 - COPD: TRANSLATIONAL AND MECHANISTIC STUDIES
A7097 - The Impact of GOLD Stage on the Effectiveness of Tiotropium/Olodaterol in Preventing COPD Exacerbations in the DYNAGITO Trial
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD
A7101 - Treatment of First Exacerbation Predicts Future Risk of Exacerbations in Patients with COPD in the DYNAGITO Trial
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD